|
2016 First Quarter Performance Summary
2016.05.20
|
|---|
|
Daehan New Pharm, listed on KOSDAQ (054670), posted first-quarter 2016 results with sales growing 15.1% year-over-year to 24.086 billion KRW and operating profit increasing 15.2% to 2.604 billion KRW, maintaining a high-growth trend for the fourth consecutive year.
The company’s strategy focuses on expanding its product portfolio, strengthening customer relationships through creative solution-based sales, overcoming limits with proactive management, and continuously creating value innovation centered on talent management while concentrating on core activities. |


Home